921
Views
46
CrossRef citations to date
0
Altmetric
Review

Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability

ORCID Icon, &
Pages 129-142 | Received 31 Oct 2018, Accepted 04 Jan 2019, Published online: 29 Jan 2019

References

  • Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2:3–14.
  • Bauer H-C, Krizbai IA, Bauer H, et al. “You shall not pass”-tight junctions of the blood brain barrier. Front Neurosci. 2014;8:392.
  • Mathiisen TM, Lehre KP, Danbolt NC, et al. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia. 2010;58:1094–1103.
  • Armulik A, Genové G, Mäe M, et al. Pericytes regulate the blood–brain barrier. Nature. 2010;468:557.
  • Thorne RG, Nicholson C. In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc Natl Acad Sci U S A. 2006;103:5567–5572.
  • Neeves KB, Sawyer AJ, Foley CP, et al. Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles. Brain Res. 2007;1180:121–132.
  • Pardridge WM. Drug transport across the blood–brain barrier. J Cereb Blood Flow Metab. 2012;32:1959–1972.
  • Doolittle ND, Miner ME, Hall WA, et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer. 2000;88:637–647.
  • Tamai I, Tsuji A. Transporter-mediated permeation of drugs across the blood–brain barrier. J Pharm Sci. 2000;89:1371–1388.
  • Taché Y, Goto Y, Gunion MW, et al. Inhibition of gastric acid secretion in rats by intracerebral injection of corticotropin-releasing factor. Science. 1983;222:935–937.
  • Hanson LR, Frey WH 2nd. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008;9(Suppl 3):S5.
  • Wang Y, Cooke MJ, Morshead CM, et al. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials. 2012;33:2681–2692.
  • Salahuddin TS, Johansson BB, Kalimo H, et al. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions: A light microscopic and immunohistochemical study. Neuropathol Appl Neurobiol. 1988;14:467–482.
  • Hynynen K, McDannold N, Vykhodtseva N, et al. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology. 2001;220:640–646.
  • O’Reilly MA, Hough O, Hynynen K. Blood-brain barrier closure time after controlled ultrasound-induced opening is independent of opening volume. J Ultrasound Med. 2017;36:475–483.
  • McDannold N, Arvanitis CD, Vykhodtseva N, et al. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012;72:3652–3663.
  • Lynn JG, Zwemer RL, Chick AJ, et al. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol. 1942;26:179–193.
  • Bakay L, Ballantine HT Jr, Hueter TF, et al. Ultrasonically produced changes in the blood-brain barrier. AMA Arch Neurol Psychiatry. 1956;76:457–467.
  • Ballantine HT Jr, Bell E, Manlapaz J. Progress and problems in the neurological applications of focused ultrasound. J Neurosurg. 1960;17:858–876.
  • Mesiwala AH, Farrell L, Wenzel HJ, et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol. 2002;28:389–400.
  • Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol. 1989;15:319–333.
  • O’Reilly MA, Hynynen K. Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions–based controller. Radiology. 2012;263:96–106.
  • Treat LH, McDannold N, Vykhodtseva N. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI‐guided focused ultrasound. J Cancer. 2007;121:901–907.
  • Treat LH, McDannold N, Zhang Y, et al. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol. 2012;38:1716–1725.
  • Kovacs Z, Werner B, Rassi A, et al. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J Control Release. 2014;187:74–82.
  • Kang J, Wu X, Wang Z, et al. Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors. J Ultrasound Med. 2010;29:61–70.
  • Alli S, Figueiredo CA, Golbourn B, et al. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery. J Control Release. 2018;281:29–41.
  • Kinoshita M, McDannold N, Jolesz FA, et al. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun. 2006;340:1085–1090.
  • Kinoshita M, McDannold N, Jolesz FA, et al. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood–brain barrier disruption. PNAS. 2006;103:11719–11723.
  • Jordão JF, Thévenot E, Markham-Coultes K, et al. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol. 2013;248:16–29.
  • Alkins R, Burgess A, Ganguly M, et al. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 2013;73:1892–1899.
  • Burgess A, Ayala-Grosso CA, Ganguly M, et al. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PLoS One. 2011;6:e27877.
  • Baseri B, Choi JJ, Deffieux T, et al. Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles. Phys Med Biol. 2012;57:N65–N81.
  • Burgess A, Huang Y, Querbes W, et al. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J Control Release. 2012;163:125–129.
  • Thévenot E, Jordão JF, O’Reilly MA, et al. Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound. Hum Gene Ther. 2012;23:1144–1155.
  • Hsu P-H, Wei K-C, Huang C-Y, et al. Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound. PLoS One. 2013;8:e57682.
  • Wang S, Olumolade OO, Sun T, et al. Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus. Gene Ther. 2015;22:104–110.
  • Lin C-Y, Hsieh H-Y, Pitt WG, et al. Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery. J Control Release. 2015;212:1–9.
  • Mead BP, Mastorakos P, Suk JS, et al. Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound. J Control Release. 2016;223:109–117.
  • Mead B, Mastorakos P, Suk JS, et al. Localized delivery of non-viral gene-bearing nanoparticles into the rat brain following focused ultrasound-mediated BBB opening. J Ther Ultrasound. 2015;3:P29.
  • Scarcelli T, Jordão JF, O’Reilly MA, et al. Stimulation of hippocampal neurogenesis by transcranial focused ultrasound and microbubbles in adult mice. Brain Stimul. 2014;7:304–307.
  • Mooney SJ, Shah K, Yeung S, et al. Focused ultrasound-induced neurogenesis requires an increase in blood-brain barrier permeability. PLoS One. 2016;11:e0159892.
  • Burgess A, Dubey S, Yeung S, et al. Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior. Radiology. 2014;273:736–745.
  • Leinenga G, Götz J. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model. Sci Transl Med. 2015;7:278ra33.
  • Poon CT, Shah K, Lin C, et al. Time course of focused ultrasound effects on β-amyloid plaque pathology in the TgCRND8 mouse model of Alzheimer’s disease. Sci Rep. 2018;8:14061.
  • Kimura T, Sharma G, Ishiguro K, et al. Phospho-Tau bar code: analysis of Phosphoisotypes of Tau and its application to tauopathy. Front Neurosci. 2018;12:55.
  • Nisbet RM, Van der Jeugd A, Leinenga G, et al. Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model. Brain. 2017;140:1220–1230.
  • Jordão JF, Ayala-Grosso CA, Markham K, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer’s disease. PLoS One. 2010;5:e10549.
  • O’Reilly MA, Jones RM, Barrett E, et al. Investigation of the safety of focused ultrasound-induced blood-brain barrier opening in a natural canine model of aging. Theranostics. 2017;7:3573–3584.
  • Jones RM, O’Reilly MA, Hynynen K. Passive mapping of acoustic sources within the human skull cavity with a hemispherical sparse array using computed tomography-based aberration corrections. J Acoust Soc Am. 2014;135:2208–2209.
  • Carpentier A, Canney M, Vignot A, et al. Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med. 2016;8:343re2–re343re2.
  • Horodyckid C, Canney M, Vignot A, et al. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model. J Neurosurg. 2017;126:1351–1361.
  • Clement GT, Hynynen K. A non-invasive method for focusing ultrasound through the human skull. Phys Med Biol. 2002;47:1219–1236.
  • Hynynen K, McDannold N, Clement G, et al. Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain–a primate study. Eur J Radiol. 2006;59:149–156.
  • McDannold N, Park E-J, Mei C-S, et al. Evaluation of three-dimensional temperature distributions produced by a low-frequency transcranial focused ultrasound system within ex vivo human skulls. IEEE Trans Ultrason Ferroelectr Freq Control. 2010;57:1967–1976.
  • Jones RM, O’Reilly MA, Hynynen K. Experimental demonstration of passive acoustic imaging in the human skull cavity using CT-based aberration corrections. Med Phys. 2015;42:4385–4400.
  • Huang Y, Alkins R, Schwartz ML, et al. Opening the blood-brain barrier with mr imaging–guided focused ultrasound: preclinical testing on a trans–human skull porcine model. Radiology. 2017;282:123–130.
  • Goldwirt L, Canney M, Horodyckid C, et al. Enhanced brain distribution of carboplatin in a primate model after blood–brain barrier disruption using an implantable ultrasound device. Cancer Chemother Pharmacol. 2016;77:211–216.
  • Lipsman N, Ironside S, Alkins R, et al. Initial experience of blood-brain barrier opening for chemotherapeutic-drug delivery to brain tumours by MR-guided focused ultrasound. Neuro Oncol. 2017;19:vi9–vi9.
  • Lipsman N, Meng Y, Bethune AJ, et al. Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound. Nat Commun. 2018;9:2336.
  • Kovacs ZI, Kim S, Jikaria N, et al. Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation. Proc Natl Acad Sci U S A. 2017;114:E75–E84.
  • McMahon D, Hynynen K. Acute inflammatory response following increased blood-brain barrier permeability induced by focused ultrasound is dependent on microbubble dose. Theranostics. 2017;7:3989–4000.
  • McMahon D, Hynynen K. Reply to Kovacs et al.: concerning acute inflammatory response following focused ultrasound and microbubbles in the brain. Theranostics. 2018;8:2249–2250.
  • H-L L, C-H P, C-Y T, et al. Opening of the blood-brain barrier by low-frequency (28-kHz) ultrasound: a novel pinhole-assisted mechanical scanning device. Ultrasound Med Biol. 2010;36:325–335.
  • Bing KF, Howles GP, Qi Y, et al. Blood-brain barrier (BBB) disruption using a diagnostic ultrasound scanner and definity® in mice. Ultrasound Med Biol. 2009;35:1298–1308.
  • Schwartz ML, Yeung R, Huang Y, et al. Skull bone marrow injury caused by MR-guided focused ultrasound for cerebral functional procedures. J Neurosurg. 2018;11:1–5.
  • Pulkkinen A, Werner B, Martin E, et al. Numerical simulations of clinical focused ultrasound functional neurosurgery. Phys Med Biol. 2014;59:1679–1700.
  • Pichardo S, Sin VW, Hynynen K. Multi-frequency characterization of the speed of sound and attenuation coefficient for longitudinal transmission of freshly excised human skulls. Phys Med Biol. 2011;56:219–250.
  • Pajek D, Hynynen K. The application of sparse arrays in high frequency transcranial focused ultrasound therapy: a simulation study. Med Phys. 2013;40:122901.
  • McDannold N, Vykhodtseva N, Hynynen K. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol. 2008;34:834–840.
  • Kovacs ZI, Tu T-W, Sundby M, et al. MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain. Theranostics. 2018;8:4837–4855.
  • Vykhodtseva N, McDannold N, Hynynen K. Induction of apoptosis in vivo in the rabbit brain with focused ultrasound and Optison®. Ultrasound Med Biol. 2006;32:1923–1929.
  • Samiotaki G, Vlachos F, Tung Y-S, et al. A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI. Magn Reson Med. 2012;67:769–777.
  • McDannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med Biol. 2008;34:930–937.
  • O’Reilly MA, Waspe AC, Ganguly M, et al. Focused-ultrasound disruption of the blood-brain barrier using closely-timed short pulses: influence of sonication parameters and injection rate. Ultrasound Med Biol. 2011/4;37:587–594.
  • Choi JJ, Selert K, Gao Z, et al. Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse repetition frequencies. J Cereb Blood Flow Metab. 2011;31:725–737.
  • Chopra R, Vykhodtseva N, Hynynen K. Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures. ACS Chem Neurosci. 2010;1:391–398.
  • Song K-H, Fan AC, Hinkle JJ, et al. Microbubble gas volume: a unifying dose parameter in blood-brain barrier opening by focused ultrasound. Theranostics. 2017;7:144–152.
  • van der Meer SM, Dollet B, Voormolen MM, et al. Microbubble spectroscopy of ultrasound contrast agents. J Acoust Soc Am. 2007;121:648–656.
  • Choi JJ, Feshitan JA, Baseri B, et al. Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo. IEEE Trans Biomed Eng. 2010;57:145–154.
  • de Jong N, Hoff L, Skotland T, et al. Absorption and scatter of encapsulated gas filled microspheres: theoretical considerations and some measurements. Ultrasonics. 1992;30:95–103.
  • Goertz DE, de Jong N, Van Der Steen AFW. Attenuation and size distribution measurements of definity and manipulated definity populations. Ultrasound Med Biol. 2007;33:1376–1388.
  • McDannold N, Zhang Y, Vykhodtseva N. The effects of oxygen on ultrasound-induced blood-brain barrier disruption in mice. Ultrasound Med Biol. 2017;43:469–475.
  • McDannold N, Vykhodtseva N, Hynynen K. Use of ultrasound pulses combined with definity for targeted blood-brain barrier disruption: a feasibility study. Ultrasound Med Biol. 2007;33:584–590.
  • Helfield BL, Huo X, Williams R, et al. The effect of preactivation vial temperature on the acoustic properties of DefinityTM. Ultrasound Med Biol. 2012;38:1298–1305.
  • Itani M, Mattrey RF. The effect of inhaled gases on ultrasound contrast agent longevity in vivo. Mol Imaging Biol. 2012;14:40–46.
  • Mullin L, Gessner R, Kwan J, et al. Effect of anesthesia carrier gas on in vivo circulation times of ultrasound microbubble contrast agents in rats. Contrast Media Mol Imaging. 2011;6:126–131.
  • Samiotaki G, Karakatsani ME, Buch A, et al. Pharmacokinetic analysis and drug delivery efficiency of the focused ultrasound-induced blood-brain barrier opening in non-human primates. Magn Reson Imaging. 2017;37:273–281.
  • Wu S-Y, Sanchez CS, Samiotaki G, et al. Characterizing focused-ultrasound mediated drug delivery to the heterogeneous primate brain in vivo with acoustic monitoring. Sci Rep. 2016;6:37094.
  • Faez T, Emmer M, Docter M, et al. Characterizing the subharmonic response of phospholipid-coated microbubbles for carotid imaging. Ultrasound Med Biol. 2011;37:958–970.
  • Sijl J, Vos HJ, Rozendal T, et al. Combined optical and acoustical detection of single microbubble dynamics. J Acoust Soc Am. 2011;130:3271–3281.
  • Leighton TG. The acoustic bubble. London: Academic Press; 1994.
  • Prosperetti A. A general derivation of the subharmonic threshold for non-linear bubble oscillations. J Acoust Soc Am. 2013;133:3719–3726.
  • Lewin PA, Bjørnø L. Acoustically induced shear stresses in the vicinity of microbubbles in tissue. J Acoust Soc Am. 1982;71:728–734.
  • Chen H, Kreider W, Brayman AA, et al. Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett. 2011;106:034301.
  • Hosseinkhah N, Hynynen K. A three-dimensional model of an ultrasound contrast agent gas bubble and its mechanical effects on microvessels. Phys Med Biol. 2012;57:785–808.
  • Hosseinkhah N, Goertz DE, Hynynen K. Microbubbles and blood-brain barrier opening: a numerical study on acoustic emissions and wall stress predictions. IEEE Trans Biomed Eng. 2015;62:1293–1304.
  • Tung Y-S, Vlachos F, Choi JJ, et al. In vivo transcranial cavitation threshold detection during ultrasound-induced blood–brain barrier opening in mice. Phys Med Biol. 2010;55:6141–6155.
  • McDannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol. 2006;51:793–807.
  • Arvanitis CD, Livingstone MS, Vykhodtseva N, et al. Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS One. 2012;7:e45783.
  • Sun T, Zhang Y, Power C, et al. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model. Proc Natl Acad Sci U S A. 2017;114:E10281–E10290.
  • Jones RM, Deng L, Leung K, et al. Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening. Theranostics. 2018;8:2909–2926.
  • Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A. 1996;93:14164–14169.
  • Sutton JT, Haworth KJ, Pyne-Geithman G, et al. Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opin Drug Deliv. 2013;10:573–592.
  • Laing ST, Kim H, Kopechek JA, et al. Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo. J Liposome Res. 2010;20:160–167.
  • Carpentier A, Canney M, Vignot A, et al. Temporary disruption of the blood-brain barrier using an implantable ultrasound system for recurrent glioblastoma patients under IV carboplatin chemotherapy: initial phase 1/2a clinical trial observations. J Ther Ultrasound. 2015;3:O14.
  • Veltkamp R, Siebing DA, Sun L, et al. Hyperbaric oxygen reduces blood–brain barrier damage and edema after transient focal cerebral ischemia. Stroke. 2005;36:1679–1683.
  • Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–174.
  • Yang F-Y, Liu S-H, Ho F-M, et al. Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption. J Acoust Soc Am. 2009;126:3344–3349.
  • Sheikov N, McDannold N, Sharma S, et al. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol. 2008;34:1093–1104.
  • Zhang Z, Xia C, Xue Y, et al. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction. J Neurosci Res. 2009;87:2282–2289.
  • Marty B, Larrat B, Van Landeghem M, et al. Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis. J Cereb Blood Flow Metab. 2012;32:1948–1958.
  • Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20:637–642.
  • Tsushima Y, Endo K. Hypointensities in the brain on T2*-weighted gradient-echo magnetic resonance imaging. Curr Probl Diagn Radiol. 2006;35:140–150.
  • Downs ME, Karakatsani ME, Buch AM, et al. Long-term safety of repeated blood-brain barrier opening via focused ultrasound with microbubbles in non-human primates performing a cognitive task. 2015;10:e0125911.
  • Downs ME, Buch A, Karakatsani ME, et al. Blood-brain barrier opening in behaving non-human primates via focused ultrasound with systemically administered microbubbles. Sci Rep. 2015;5:15076.
  • Raymond SB, Treat LH, Dewey JD, et al. Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer’s disease mouse models. PLoS One. 2008;3:e2175.
  • Sheikov N, McDannold N, Vykhodtseva N, et al. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol. 2004;30:979–989.
  • Jones R, Deng L, Leung K, et al. Repeated hippocampal blood-brain barrier opening controlled via three-dimensional transcranial acoustic imaging: safety study in a porcine model. 2017 IEEE International Ultrasonics Symposium (IUS), Washington DC. 2017. p. 1.
  • Hynynen K, McDannold N, Sheikov NA, et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage. 2005;24:12–20.
  • Baseri B, Choi JJ, Tung Y-S, et al. Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. Ultrasound Med Biol. 2010;36:1445–1459.
  • McMahon D, Bendayan R, Hynynen K. Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome. Sci Rep. 2017;7:45657.
  • Kobus T, Vykhodtseva N, Pilatou M, et al. Safety validation of repeated blood-brain barrier disruption using focused ultrasound. Ultrasound Med Biol. 2016;42:481–492.
  • McDannold N, Vykhodtseva N, Raymond S, et al. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol. 2005;31:1527–1537.
  • Hynynen K, McDannold N, Vykhodtseva N, et al. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg. 2006;105:445–454.
  • Liu H-L, Wai -Y-Y, Hsu P-H, et al. In vivo assessment of macrophage CNS infiltration during disruption of the blood-brain barrier with focused ultrasound: a magnetic resonance imaging study. J Cereb Blood Flow Metab. 2010;30:177–186.
  • McMahon D, Mah E, Hynynen K. Angiogenic response of rat hippocampal vasculature to focused ultrasound-mediated increases in blood-brain barrier permeability. Sci Rep. 2018;8:12178.
  • Shaw CE, Dunbar PR, Macaulay HA, et al. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission. J Neurol. 1995;242:53–58.
  • Sharief MK, Thompson EJ. Increased levels of circulating ICAM-1. in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-a and blood-brain barrier damage. J Neuroimmunol. 1993;43:15–22.
  • Lu J, Moochhala S, Kaur C, et al. Cellular inflammatory response associated with breakdown of the blood-brain barrier after closed head injury in rats. J Neurotrauma. 2001;18:399–408.
  • Breckwoldt MO, Chen JW, Stangenberg L, et al. Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc Natl Acad Sci U S A. 2008;105:18584–18589.
  • Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184:53–68.
  • Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol. 2003;62:127–136.
  • Bolton SJ, Perry VH. Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp Neurol. 1998;154:231–240.
  • Cacheaux LP, Ivens S, David Y, et al. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci. 2009;29:8927–8935.
  • Voutsinos-Porche B, Koning E, Kaplan H, et al. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol Dis. 2004;17:385–402.
  • Kotas ME, Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell. 2015;160:816–827.
  • Pekny M, Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev. 2014;94:1077–1098.
  • Pekny M, Wilhelmsson U, Pekna M. The dual role of astrocyte activation and reactive gliosis. Neurosci Lett. 2014;565:30–38.
  • Hu X, Leak RK, Shi Y, et al. Microglial and macrophage polarization—new prospects for brain repair. Nat Rev Neurol. 2015;11:56–64.
  • Lucas S-M, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147(Suppl 1):S232–S240.
  • O’Reilly MA, Jones RM, Hynynen K. Three-dimensional transcranial ultrasound imaging of microbubble clouds using a sparse hemispherical array. IEEE Trans Biomed Eng. 2014;61:1285–1294.
  • Deng L, O’Reilly MA, Jones RM, et al. A multi-frequency sparse hemispherical ultrasound phased array for microbubble-mediated transcranial therapy and simultaneous cavitation mapping. Phys Med Biol. 2016;61:8476–8501.
  • Crake C, Brinker ST, Coviello CM, et al. A dual-mode hemispherical sparse array for 3D passive acoustic mapping and skull localization within a clinical MRI guided focused ultrasound device. Phys Med Biol. 2018;63:065008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.